CoMira™ Logix Smart® Zika Virus (ZIKV) test kit
Boost speed and accuracy with real-time PCR testing
How It Works
Ready-to-use Master Mix
Ready-to-use Master Mix with Internal Positive Control (Human RNaseP)
Positive Control
Synthetic positive control that targets all included markers
Negative Control
Verifies Master Mix contamination-free status
Applications
Clinical Diagnosis
Qualitative RT-PCR screening for diagnosis of Zika virus infection in symptomatic patients.
Prenatal Screening
Critical testing for pregnant women or those planning pregnancy, especially with travel history.
Donor Screening
Screening for blood transfusion and organ transplantation to prevent virus transmission.
Benefits
Early & Accurate Diagnosis
Detects virus during acute infection phase for timely intervention
Prevents Transmission
Helps prevent virus transmission before pregnancy, transfusion, or sexual contact
Multiple Sample Types
Compatible with serum, plasma, and urine specimens
CE Mark Approved
CE mark approval in October 2018 for clinical diagnostic use
Broad Detection
Detects both African and Asian lineages of Zika virus
Key Specifications
| Application | Qualitative RT-PCR screening |
| Sample Types | Serum, plasma, urine |
| Sensitivity | Asian lineage: 93% (86-98%); African: 100% |
| Specificity | 100% (96-100%) |
| Time to Result | 81 minutes |
| LOD (Serum) | 35 copies/μL |
| LOD (Urine) | 30-130 copies/μL |
Request Product Information
Contact us to learn more about the CoMira Logix Smart Zika test and how it can support your Zika virus testing programs.
Contact Us